Search Within

Lisa De Angelis

  1. "2013"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (10)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (24)
  2. Epidemiology and Biostatistics (7)
  3. Population Sciences Research Program (7)
  4. Biostatistics Service (6)
  5. GSK Faculty (6)
  6. Human Oncology and Pathogenesis Program (6)

More Groups

People
  1. Antonio Omuro (12)
  2. Lauren Abrey (6)
  3. Katherine Panageas (5)
  4. Ingo Mellinghoff (4)
  5. Andrew Lassman (3)
  6. Anne Reiner (3)

More People

Years
  1. 2013 (24)
Publications
  1. Neuro-Oncology (8)
  2. Journal of Clinical Oncology (3)
  3. Journal of Clinical Neurophysiology (2)
  4. Journal of Neuro-Oncology (2)
  5. Neurology (2)
  6. Annual Review of Medicine (1)

More Publications

Publishers
  1. Oxford University Press (8)
  2. Springer (4)
  3. American Society of Clinical Oncology (3)
  4. American Clinical Neurophysiology Society (2)
  5. Lippincott Williams & Wilkins (2)
  6. American Medical Association (1)

More Publishers

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of the phosphatidyinositol-3 kinase (PI3K) inhibitor BKM120 in recurrent glioblastoma (GBM)
    Meeting Abstract

    Wen, P. Y.; Yung, W. K. A.; Mellinghoff, I. K.; Lamborn, K.; Ramkissoon, S.; Cloughesy, T. F.; Rinne, M.; Omuro, A. M. P.; DeAngelis, L. M.; Gilbert, M. R.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I trial of temsirolimus (TEM) and perifosine (PER) for recurrent or progressive malignant glioma (MG)
    Meeting Abstract

    Kaley, T. J.; Pentsova, E.; Omuro, A. M. P.; Mellinghoff, I. K.; Nolan, C.; Gavrilovic, I. T.; DeAngelis, L. M.; Lacouture, M. E.; Holland, E. C.; Lassman, A. B.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of the phosphatidyinositol-3 kinase (Pi3k) inhibitor buparlisib (Bkm120) in recurrent glioblastoma: An Ivy Foundation early phase clinical trials consortium study
    Meeting Abstract

    Wen, P.; Yung, A.; Mellinghoff, I.; Lamborn, K.; Ramkissoon, S.; Cloughesy, T.; Rinne, M.; Omuro, A.; DeAngelis, L.; Gilbert, M.; more...
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Temozolomide followed by high-dose chemotherapy and autologous stem cell transplant (Hdc-Asct) for newly diagnosed anaplastic oligodendroglioma (AO): Can radiotherapy be deferred?
    Meeting Abstract

    Omuro, A.; Abrey, L.; Raizer, J.; Paleologos, N.; Forsyth, P.; DeAngelis, L.; Kaley, T.; Louis, D.; Cairncross, J. G.; Matasar, M.; more...
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • An open-label, multi-center, phase II study of Patupilone (Epo906), in the treatment of recurrent or progressive brain metastases in patients with non-small cell lung cancer (Nsclc)
    Meeting Abstract

    Nayak, L.; Omuro, A.; DeAngelis, L.; Robins, H. I.; Govindan, R.; Gadgeel, S.; Kelly, K.; Rigas, J.; Reimers, H. J.; Peereboom, D.; more...
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • The neurologic assessment in neuro-oncology (Nano) scale: A tool to assess neurologic function for integration in the radiologic assessment in neuro-oncology (Rano) criteria
    Meeting Abstract

    Nayak, L.; Deangelis, L. M.; Wen, P. Y.; Brandes, A. A.; Soffietti, R.; Peereboom, D. M.; Lin, N. U.; Chamberlain, M.; Macdonald, D.; Galanis, E.; more...
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Prognostic awareness (PA) and communication of prognostic information in malignant glioma (MG): A systematic review
    Meeting Abstract

    Diamond, E.; Applebaum, A.; Corner, G.; DeRosa, A.; Breitbart, W.; DeAngelis, L.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Unconfirmed complete response (CRU) in patients with primary central nervous system lymphoma (PCNSL)
    Meeting Abstract

    De La Fuente, M.; Omuro, A.; DeAngelis, L.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Apoe genotype and cognitive outcome in patients with brain tumors
    Meeting Abstract

    Correa, D.; Satagopan, J.; Baser, R.; Cheung, K.; Lin, M.; Karimi, S.; Lyo, J.; DeAngelis, L.; Orlow, I.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome
    Journal Article

    Morris, P. G.; Correa, D. D.; Yahalom, J.; Raizer, J. J.; Schiff, D.; Grant, B.; Grimm, S.; Lai, R. K.; Reiner, A. S.; Panageas, K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save